» Articles » PMID: 24504258

Clinical Outcomes and Inflammatory Markers Should Be Kept in Mind when Assessing the Mean Platelet Volume in Patients with Infective Endocarditis

Overview
Journal Med Princ Pract
Publisher Karger
Date 2014 Feb 8
PMID 24504258
Authors
Affiliations
Soon will be listed here.
References
1.
Gunebakmaz O, Gungor Kaya M, Kaya E, Ardic I, Yarlioglues M, Dogdu O . Mean platelet volume predicts embolic complications and prognosis in infective endocarditis. Int J Infect Dis. 2010; 14(11):e982-5. DOI: 10.1016/j.ijid.2010.05.019. View

2.
Heiro M, Helenius H, Sundell J, Koskinen P, Engblom E, Nikoskelainen J . Utility of serum C-reactive protein in assessing the outcome of infective endocarditis. Eur Heart J. 2005; 26(18):1873-81. DOI: 10.1093/eurheartj/ehi277. View

3.
Olaison L, Hogevik H, ALESTIG K . Fever, C-reactive protein, and other acute-phase reactants during treatment of infective endocarditis. Arch Intern Med. 1997; 157(8):885-92. View

4.
Turak O, Ozcan F, Isleyen A, Basar F, Gul M, Yilmaz S . Usefulness of neutrophil-to-lymphocyte ratio to predict in-hospital outcomes in infective endocarditis. Can J Cardiol. 2013; 29(12):1672-8. DOI: 10.1016/j.cjca.2013.05.005. View

5.
Icli A, Tayyar S, Varol E, Aksoy F, Arslan A, Ersoy I . Mean platelet volume is increased in infective endocarditis and decreases after treatment. Med Princ Pract. 2012; 22(3):270-3. PMC: 5586739. DOI: 10.1159/000345393. View